Author:
Chow B. K-C,Pang R. T-K,Ng S. S-M
Reference110 articles.
1. Adamou JE, Aiyar N, Van Horn S, Elshourbagy NA. Cloning and functional characterization of the human vasoactive intestinal peptide (VIP)-2 receptor. Biochem Biophys Res Commun 1995;209:385–392.
2. Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals. Endocrinology 1999;140:1285–1293.
3. Alexandre D, Vaudry H, Jegou S, Anouar Y. Structure and distribution of the mRNAs encoding pituitary adenylate cyclase-activating polypeptide and growth hormone-releasing hormone-like peptide in the frogRana ridibunda.J Comp Neurol 2000;421:234–246.
4. Alexandre D, Anouar Y, Turquier V, Jegou S, Vandesande F, Fournier A, Vaudry H. Identification and tissue-distribution of novel splice variants of Type I PACAP receptor in the frogRana ridibunda.In: Goos HJT, Rastogi RK, Vaudry H, Pierantoni R, eds. Perspective in comparative endocrinology: unity and diversity. Monduzzi Editore; 2001:1225–1231.
5. Arimura A, Shioda S. Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front Neuroendocrinol 1995;16:53–88.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Secretin Superfamily: PACAP, VIP, and Related Neuropeptides;Handbook of Neurochemistry and Molecular Neurobiology;2006